|本期目录/Table of Contents|

[1]丁永慧,徐永辉.MDM2和p53在宫颈鳞癌中的表达及与高危型HPV感染的关系[J].宁夏医科大学学报,2013,(01):26-28.
 DING Yong-hui,XU Yong-hui.Relationship between Expression of MDM2,p53 and HR-HPV in Patients with Cervical Squamous Cancer[J].Ningxia Medical University,2013,(01):26-28.
点击复制

MDM2和p53在宫颈鳞癌中的表达及与高危型HPV感染的关系(PDF)
分享到:

《宁夏医科大学学报》[ISSN:1005-8486/CN:64-1029/R]

卷:
期数:
2013年01期
页码:
26-28
栏目:
论著
出版日期:
2013-01-20

文章信息/Info

Title:
Relationship between Expression of MDM2,p53 and HR-HPV in Patients with Cervical Squamous Cancer
作者:
丁永慧1 徐永辉2
1.宁夏医科大学总医院妇科,银川 750004; 2.宁夏医科大学总医院病理科,银川 750004
Author(s):
DING Yong-hui1 XU Yong-hui2
1.Dept. of Gynecology, the General Hospital of Ningxia Med. Univ.,Yinchuan 750004; 2.Dept.of Pathology,the General Hospital of Ningxia Med. Univ.,Yinchuan 750004
关键词:
宫颈鳞癌 MDM2 p53 高危型人乳头瘤病毒
Keywords:
cervical squamous cancer MDM2 p53 high risk human papillomavirus
分类号:
R737.33
DOI:
-
文献标志码:
A
摘要:
目的 探讨宫颈鳞癌组织中MDM2、p53的表达及与高危型人乳头瘤病毒(HPV)感染的关系。方法 选取实验组30例宫颈鳞癌组织及对照组20例正常宫颈组织,石蜡包埋后,采用免疫组化法检测组织中MDM2、p53蛋白的表达; 采用杂交捕获二代实验(HC2)的方法检测实验组及对照组宫颈分泌物中高危型HPV 的表达。结果 MDM2、p53在宫颈鳞癌组织中的表达阳性率分别为90%、86.7%,高危型HPV(HR-HPV)在宫颈鳞癌患者宫颈分泌物中的检出率为83.3%; p53在HR-HPV阳性的宫颈鳞癌患者中阳性表达率为92%,与对照组比较差异均有统计学意义(P<0.05); 经Spearman相关分析显示,P53与高危型HPV在宫颈鳞癌中的表达呈正相关(r=0.822,P<0.05)。结论 MDM2、p53与宫颈鳞癌的发生有关; 高危型HPV感染可能是p53由抑癌基因转变为癌基因的关键因素。
Abstract:
Objective To detect the expression of MDM2,p53 and HR-HPV in patients with cervical cancer. Methods(1)The expressions of MDM2,p53 were observed by immunihistochemisty in the cervical cancer tissues of 30 cases with cervical squamous cancer and the normal cervial tissues of 20 cases as controls.(2)The expressions of HR-HPV were observed by HC2 in the cervical squamous cancer tissues and normal cervica l tissues. Results The positive expression of MDM2、p53 lied in nucleus and the positive rate were 90% and 86.7%. The positive rate of HR-HPV in cervical squamous cancer was 83.3%. There was significantly statistical difference in MDM2 and P53 between and cervical squamous cancer tissues and normal cervical tissues. Conclusion The expression of MDM2 and p53 may be a key role in occurrence of cervical squamous cancer.

参考文献/References:

[1] 乐杰,谢幸,林仲秋,等.妇产科学[M].7版.北京:人民卫生出版社,2008:263.
[2] 丁永慧,张治宁. Bcl2、Bax在卵巢子宫内膜异位囊肿中的表达及意义[J].宁夏医学杂志,2009,31(12):1143-1144.
[3] 刘娜,王英红,阿曼古丽.HC2检测高危型HPV-DNA载量与子宫颈病变的关系[J].中国妇幼保健,2010,25(28):4138-4142.
[4] 郭珍珍,陈作良.P53、Bel-2、MDM2和P52在口腔鳞癌中的表达及相关研究[J].福建医药杂志,2012,34(4):144-145
[5] 朱靖,周颖,凌斌.野生型p53及其凋零基因与子宫颈癌发病机制[J].国际妇产科学杂志,2010,37(3):187-189.
[6] 溥纯美.p53及PCNA在子宫颈癌中的表达及临床意义[J].滨州医学院学报,2009,32(3):190-191.
[7] 宋亚辉,刘青云,张林.VEGF和p53在宫颈癌中的表达[J].现代生物医学进展,2010,10(2):313-315.
[8] 王晓英,黄永宏,张宏伟,等.Ki67、p53、Survivin在宫颈癌、宫颈上皮内癌变及宫颈炎中的表达及意义[J].山东医药,2010,50(25):88-89.
[9] Massimi P,Shai A,Lambert P,et al.HPV E6 degradation of p53 and PDZ containing substrates in an E6AP null background[J]. Oncogene,2008,27(12):1800-1809.

相似文献/References:

[1]王成泉,王珺,尹磊,等.裸鼠体内人U343胶质瘤中Period2对胶质瘤p53的调控作用及意义[J].宁夏医科大学学报,2015,(06):620.[doi:10.16050/j.cnki.issn1674-6309.2015.06.004]
 WANG Chengquan,WANG Jun,YIN Lei,et al.[J].Ningxia Medical University,2015,(01):620.[doi:10.16050/j.cnki.issn1674-6309.2015.06.004]
[2]尹明伟,辛淑文,隋御,等.下调REV3通过激活p53诱导结肠癌细胞THC-8307凋亡[J].宁夏医科大学学报,2015,(03):237.[doi:10.16050/j.cnki.issn1674-6309.2015.03.002 ]
 YIN Mingwei,XIN Shuwen,SUI Yu,et al.[J].Ningxia Medical University,2015,(01):237.[doi:10.16050/j.cnki.issn1674-6309.2015.03.002 ]
[3]张薇,何丽萍,李建宁,等.p53抑制剂PFT-α对犬博卡病毒感染致靶细胞病变的影响[J].宁夏医科大学学报,2015,(01):9.[doi:10.16050/j.cnki.issn1674-6309.2015.01.003]
 ZHANG Wei,HE Liping,LI Jianning,et al.[J].Ningxia Medical University,2015,(01):9.[doi:10.16050/j.cnki.issn1674-6309.2015.01.003]
[4]罗金萍,车淑梅,党燕,等.宫颈ASC-H患者的临床诊断与处理[J].宁夏医科大学学报,2015,(11):1363.[doi:10.16050/j.cnki.issn1674-6309.2015.11.038 ]
[5]周晓明,张国昌,李 锋,等.P53、P21ras、Ki-67蛋白的表达及微血管密度 与甲状腺癌转移关系的研究[J].宁夏医科大学学报,2005,(06):443.[doi:10.3969/j.issn.1674-6309.2005.06.006]
 ZHOU Xiao-ming,ZHANG Guo-chang,LI Feng,et al.Clinical Significance of P53、P21ras、Ki-67 and MVD in Thyroid Carcinoma[J].Ningxia Medical University,2005,(01):443.[doi:10.3969/j.issn.1674-6309.2005.06.006]
[6]胡 蓉,李国富.组织蛋白酶在宫颈鳞癌中的表达及临床意义[J].宁夏医科大学学报,2005,(03):185.[doi:10.3969/j.issn.1674-6309.2005.03.006]
 HU Rong,LI Guo-fu.A Study on Cath-D Expression of Cervical Squamous Cell Carcinoma[J].Ningxia Medical University,2005,(01):185.[doi:10.3969/j.issn.1674-6309.2005.03.006]
[7]张晓梅,于黎明.p185蛋白在宫颈鳞癌组织中的表达及其意义[J].宁夏医科大学学报,2005,(02):91.[doi:10.3969/j.issn.1674-6309.2005.02.003]
 ZHANG Xiao-mei,YU Li-ming.A Study on p185 Expression and its Significance in Squamous Cell Carcinoma of Cervix[J].Ningxia Medical University,2005,(01):91.[doi:10.3969/j.issn.1674-6309.2005.02.003]
[8]姜怡邓,张慧萍,张鸣号,等.妊娠高血压综合征患者血清中抗氧化物与胎盘Bax、Bcl-2关系的探讨[J].宁夏医科大学学报,2007,(03):240.
 JIANG Yi-deng,ZHANG Hui-ping,ZHANG Ming-hao,et al.Relationship Between Serum Antioxidants and the Expression of Bcl-2、Bax Apoptosis Protein of Placental Tissues with Pregnancy-induced Hypertension Syndrome[J].Ningxia Medical University,2007,(01):240.
[9]马秀萍,张建中,景 丽,等.COX-2、P53、MDR-1/P-gp在乳腺癌中的表达 及其关系研究[J].宁夏医科大学学报,2011,(05):455.
 MA Xiu-ping,ZHANG Jian-zhong,JING Li,et al.The Expression of COX-2、P53 and MDR-1/P-gp in Breast Cancer[J].Ningxia Medical University,2011,(01):455.
[10]吴 蔚,张雪玉,杨彩虹,等.HMGB1和VEGF-C在宫颈鳞癌中的表达及意义[J].宁夏医科大学学报,2012,(07):699.
 WU Wei,ZHANG Xue-yu,YANG Cai-hong,et al.The Expression and Significance of HMGB1 and VEGF-C Protein in Human Cervical Squamous Cell Carcinoma[J].Ningxia Medical University,2012,(01):699.

备注/Memo

备注/Memo:
收稿日期:2012-08-21 基金项目:宁夏自然科学基金(NZ10151) 作者简介:丁永慧(1970-),女,副主任医师,硕士,从事妇产科临床工作。
更新日期/Last Update: 2013-01-20